Please login to the form below

Not currently logged in


This page shows the latest AveXis news and features for those working in and with pharma, biotech and healthcare.

Astellas makes gene therapy a core focus with $3bn Audentes buy

Astellas makes gene therapy a core focus with $3bn Audentes buy

However it is in line with recent acquisitions of gene therapies by big pharma companies, such as Novartis’ $8.7bn AveXis takeover and Roche’s still-to-be-consummated purchase of

Latest news

More from news
Approximately 4 fully matching, plus 20 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...